underutilizaton of rh prophylaxis in the emergency department: a retrospective survey
TRANSCRIPT
![Page 1: Underutilizaton of Rh prophylaxis in the emergency department: A retrospective survey](https://reader030.vdocument.in/reader030/viewer/2022020515/5750224b1a28ab877ea41447/html5/thumbnails/1.jpg)
BRIEF REPORT
Rh prophylaxis
Underutilization of Rh Prophylaxis in the
Emergency Department: A Retrospective Survey
Front the Emergency Medicine
Residency Program* and the
Department of Emergency
Medicine, t Foothills Hospital,
Calgar), Alberta, Canada.
Submitted for publication July ] 7,
1991. Accepted for publication
September 10, 1991.
Jeff Grant, MD*
Mark Hyslop, MD, FRCPC t Study objective: To determine the practice of emergency physicians with regard to the issue of Rh isoimmunization.
Design: A retrospective chart review.
Setting: A university-affiliated tertiary care hospital emergency department.
Type of par t ic ipants : Pregnant women presenting with a risk factor for Rh sensitization.
Measurements and main results: One hundred thirty-eight patient encounters were analyzed descriptively as to whether they were candidates for Rh immune prophylaxis, and if so, whether it was given. Most (68%) were hospitalized. Of those, all were Rh typed, but two patients were not given Rh immune globulin (RhlG) when indicated. Of those discharged from the ED, most (86%) were not Rh typed, and none was administered RhlG.
Conclusion: This study demonstrates a need for increased attention to the potential for Rh isoimmunization in patients presenting to the ED. [Grant J, Hyslop M: Underutilization of Rh prophylaxis in the emergency department: A retrospective survey. Ann Emerg Med February 1991 ;21:181-183.]
INTRODUCTION
Rhesus (Rh) isoimmunization occurring before delivery contin- ues to affect a significant number of Rh-negative women) -3 This
occurs despite efforts to reduce this number by improved Rh
immune globulin (RhIG) prophylaxis for women who have events
during their pregnancies that place them at increased risk. These
events include spontaneous or elective abortions, ectopic preg-
nancies, antepartum hemorrhage, and other causes of potential fetomaternal transplacental hemorrhage such as trauma. 1'2'z~
Our study was designed to examine the practice of emergency
physicians with regard to the issue of Rh isoimmunization. I~
184/181 ANNALS OF EMERGENCY MEDICINE 21:2 FEBRUARY1992
![Page 2: Underutilizaton of Rh prophylaxis in the emergency department: A retrospective survey](https://reader030.vdocument.in/reader030/viewer/2022020515/5750224b1a28ab877ea41447/html5/thumbnails/2.jpg)
Rh PROPHYLAXIS
Grant & Hyslop
METHODS AND MATERIALS A retrospective survey of
patients presenting to the
emergency department of a
large university-affiliated
tertiary care hospital was
undertaken. The survey
encompassed the three-month
period from January 1, 1990,
through March 31, 1990, and
included all patients seen
initially in the ED and dis-
charged with a diagnosis of
pregnancy-associated bleed-
ing, eetopic pregnancy, or
pregnancy associated with
abdominal trauma. Each
patient's age, gravidity, blood
type, history of previous Rh
isoimmunization, administra-
tion of RhIG, and immediate
disposition were extracted
from each chart by one
investigator.
RESULTS
One hundred thirty-eight
patient encounters involving
128 patients were analyzed
(ten patients were seen twice).
Maternal ages ranged from 15
to 46 years (mean age, 28
years), and gravidity ranged
from 1 to 10 (mean gravidity,
2.6). No patient had a docu-
mented history of previous
isoimmunization. The spec-
trum of discharge diagnoses is
given (Table).
The majority of patients
(68%) were admitted to the
hospital from the ED and dis-
charged with diagnoses of
incomplete abortions (after
dilation and curettage) or
ectopic pregnancies (after
surgery). Of those seen in and
discharged from the ED,
almost all were considered to
have threatened abortions.
The one patient with ectopic
pregnancy was discharged
against medical advice. No
patient had a discharge diag-
nosis of abdominal trauma
and pregnancy.
Rh status was noted on the
chart for all admitted patients
(confirmed by blood type and
antibody screen) but only six
of 44 discharged patients
(14%), leaving 38 of 44 (86%)
who had no notation of Rh
status documented.
Several points are worthy of
mention. In the group admit-
ted to hospital, 14 of 94 were
Table.
Spectrum offinal diagnoses from 138 patient encounters
Discharge No, of Patients No. of Patients Diagnosis Admitted Discharged Threatened abortion 3 38
Incomplete abortion 52 1
Inevitable abortion 1 1
Missed abortion 4 0
Blighted ovum 1 0
Intrauterine death I 0
Ectopic pregnancy 26 1
Spontaneous abortion 2 O
Completed abortion 4 3
Total 94 44
Rh negative (15%), but two
of 14 (14%) were not given
RhIG. One had a postsurgical
eetopic pregnancy, and the
other had a primigravid
incomplete abortion after
dilation and curettage.
Neither was previously sen-
sitized, nor was the father's
blood type noted. No test to
detect fetomaternal transfu-
sion (Kleihaur-Betke) was
performed.
Of the 44 patients
discharged from the ED, only
one was noted to be Rh nega-
tive but not given RhIG.
Discharge diagnosis was of a
threatened abortion; no formal
type and antibody screen
were done; no Kleihaur-Betke
testing was done; and there
was no specific early follow-
up advised. The father's blood
type was documented as Rh
positive. Of the remaining 38
patient encounters who had
no documented Rh type ("Rh
unknown"), 16 of 38 (42%)
had blood type documented
on readily available old charts
(requested in only five eases).
Only ten of 38 patients (26%)
had a specific early follow-up
plan with a physieian. No
patient was offered or given
RhIG in the ED.
DISCUSSION In the past 25 years, no pro-
gram has been more success-
ful in the improvement of fetal
outcome than that of preven-
tion of Rh isoimmunization in
Rh-negative women bearing
Rh-positive children) '2
Administration of RhlG in the
postpartum period alone has
been shown to decrease the
likelihood of maternal anti-D
sensitization by a factor of 10,
fiom approximately I6% to
1.5% to 2.0%. 1-3 It appears
that most of the remaining
1.5% to 2.0% are sensitized
before delivery and that the
incidence of sensitization is
increased by certain antepar-
turn events that may involve
or precipitate fetomaternal
transplacental hemorrhage. 1 4
These events include any
vaginal bleeding in pregnan-
cy, such as threatened abor-
tions, as well as ectopic preg-
nancies and some cases of
abdominal trauma) '2'¢
Current recommendations for
the administration of Rh pro-
phylaxis include the above
events in any Rh-negative
individual who may be carry-
ing an Rh-positive fetus. 1-2
The administration of the
RhIG appears to convey little
risk, 1'2 with the potential to
avoid some of the complica-
tions associated with subse-
quent pregnancies in an Rh-
sensitized mother carrying
another Rh-positive fetus,
such as repeated amniocente-
sis, intrauterine transfusions,
and fetal death. 1'2
Previous authors have
expressed concern about the
lack of emphasis on the
potential for Rh isoimmuniza-
tion in patients with threat-
ened abortions. 5'6 The pres-
ent study appears to confirm
this. Although the numbers
are small, the vast
FEBRUARY1992 21:2 ANNALS 0F EMERGENCY MEDICINE 1 8 2 / 1 0 5
![Page 3: Underutilizaton of Rh prophylaxis in the emergency department: A retrospective survey](https://reader030.vdocument.in/reader030/viewer/2022020515/5750224b1a28ab877ea41447/html5/thumbnails/3.jpg)
Rh P R O P H Y L A X I S
Grant & Hyslop
majority of patients seen in and discharged from the ED
had no documentation of Rh
status. Many had blood types
noted on charts from previous
admissions that were readily
available on request. In addi-
tion, most discharges did not
include specific early follow-
up plans (which would give a further chance for considera-
tion of Rh prophylaxis).
We recommend that emer-
gency physicians carefully
consider the potential for Rh
isoimmunization in their preg-
nant patients, with considera-
tion of RhIG prophylaxis for
those deemed at risk. The
dose of RhlG required will
vary depending on circum-
stances; 50 pg IM is consid- ered adequate for first-
trimester bleeding with 300
pg IM for later bleeding, and
dosing for abdominal trauma
should be based on results of
screening for transplacental
hemorrhage (Kleihaur-Betke
test for fetal red blood cells in the maternal circulation))' 2,7
Antibody screening should
always be performed so that
RhIG is not wasted when the mother is already sensitized, s'9
It is also important that the
blood bank and patient's
physician be notified of RhlG
administration, as this will be
useful information in the
interpretation of subsequent
tests for development of Rh
sensitization) °
C O N C L U S I O N
A large proportion of patients
at risk for Rh sensitization are
seen only by emergency
physicians. Of those, most are
managed without any atten-
tion to Rh status. Maternal Rh
type should be documented
in the ED as automatically as
tetanus immunization
status. •
The authors acknowledge the invaluable assistance
provided by the Health
Records Department,
Foothills Hospital; by Dr J
Jarrell, who provided
manuscript review; and by Ms
Lynn Soum, who prepared the
manuscript.
R E F E R E N C E S 1. Bowman JM: Controversies in Rh prophylaxis. Am J Obstet Gynecol 1985;151:289-294. 2. McMaster Conference on Prevention of Rh Immunization. Vox Sang 1977;36:50-64. 3. Mollison PL: Clinical aspects of Rh immunization. Am J Clin Pathol 1978;60:287-391. 4. Jorgensen J: Feto-maternal bleeding. Acta Obstet Gynecol Scand 1977;96:487-490. 5. Dayton VD, Anderson DS, Corsson JT, et ah A case of Rh isoimmunization: Should threatened first-trimester abortion be an indication for Bh immune globulin prophy[axis? Am J Obstet Gynecol 1990;163:63-64. 6. Huchcroft S, Gunton P, Bowen T: Compliance with postpartum Rh isoim- munization prophylaxis in Alberta. Can Med Assoc J 1985;133:871-875. 7. Rose PG, Strohm PL, Zuspan FP: Fetomaternal hemorrhage following trauma. Am J Obstet Gyneco11985;153:844-84 7. 8. Bowman JM, Pollock JM: Reversal of Bh alloimmunizatian - - Fact or fancy? Vox Sang 1984; 47:209 -215. 9. de Silva M, Contreras M, Mollison PL: Failure of passively administered anti-Rh to prevent secondary Rh responses. VoxSang 1985;48:178-180. 10. Pisciotto P, Gorbants I, Sundra M: Antenatal Rh immunoglobulin - - Help or hindrance? Transfusion 1985;25:88.
Address for reprints: Jeff Grant, MD,
Department of Emergency Medicine,
FoothiLls Hospital C231, 1403-29
Street NW, Calgary, Alberta, Canada
T2N 2T9,
1 0 6 / 1 8 3 ANNALSDF EMERGENOYMEDICINE 21:2 FEBRUARY1992